Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib vs Etanercept for NSAID and Corticosteroid Tapering in Rheumatoid Arthritis
NCT04485325Phase 4Completed
- Sponsor
- Dr. Frank Behrens
- Start
- Nov 2019
- Primary completion
- Mar 2024
- Modality
- Small Molecules, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of tofacitinib, etanercept in rheumatoid arthritis (RA), sponsored by Dr. Frank Behrens. Started Nov 2019; status: completed.
02
Drugs
tofacitinibetanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT04485325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04485325.